Status:
UNKNOWN
Metabolomic Profile in Dry Eye Syndrome Patients.
Lead Sponsor:
Ifocus Oyeklinikk
Collaborating Sponsors:
The Research Council of Norway
Conditions:
Dry Eye Syndromes
Cataract
Eligibility:
All Genders
40-90 years
Phase:
PHASE4
Brief Summary
The primary objective is to determine possible implications of deviant tear film quality for optimal refractive precision in patients scheduled for cataract surgery. The study consist of three separa...
Detailed Description
The participants will be randomized to either standard pre- and postoperative treatment protocol - hereby called the standard protocol - or a pre- and postoperative protocol where intensive dry eye tr...
Eligibility Criteria
Inclusion
- Indication for cataract surgery
- Signed informed consent
- no rheumatological or other systemic disease that involve the corneal surface
- a good ocular health with no pathology that compromises visual acuity (except cataract).
Exclusion
- Manifest corneal disease or scarring
- Lid deformities
- Corneal ectasia
- Rheumatoid diseases or other systemic diseases that involve the corneal surface,
- Recent ocular surgery
- Previous refractive procedures
- Diabetic retinopathy
- Subjects who have an acute or chronic disease or illness that would confound the results of this investigation (e.g., immunocompromised, connective tissue disease, clinically significant atopic disease, diabetes, and any other such disease or illness)
- Pregnancy.
Key Trial Info
Start Date :
August 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 23 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05433428
Start Date
August 3 2020
End Date
May 23 2023
Last Update
June 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ifocus øyeklinikk
Haugesund, Norway, 5521